title: Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin.
abstract: Nucleophosmin (NPM) is a nucleolar phosphoprotein that is involved in many cellular processes and has both oncogenic and growth suppressing activities. NPM is localized primarily in nucleoli but shuttles between the nucleus and the cytoplasm, and sustained cytoplasmic distribution contributes to its tumor promoting activities. Plakoglobin (PG, γ-catenin) is a homolog of β-catenin with dual adhesive and signaling functions. These proteins interact with cadherins and mediate adhesion, while their signaling activities are regulated by association with various intracellular partners. Despite these similarities, β-catenin has a well-defined oncogenic activity, whereas PG acts as a tumor/metastasis suppressor through unknown mechanisms. Comparison of the proteomic profiles of carcinoma cell lines with low- or no PG expression with their PG-expressing transfectants has identified NPM as being upregulated upon PG expression. Here, we examined NPM subcellular distribution and in vitro tumorigenesis/metastasis in the highly invasive and very low PG expressing MDA-MB-231 (MDA-231) breast cancer cells and their transfectants expressing increased PG (MDA-231-PG) or NPM shRNA (MDA-231-NPM-KD) or both (MDA-231-NPM-KD+PG). Increased PG expression increased the levels of nucleolar NPM and coimmunoprecipitation studies showed that NPM interacts with PG. PG expression or NPM knockdown decreased the growth rate of MDA-231 cells substantially and this reduction was decreased further in MDA-231-NPM-KD+PG cells. In in vitro tumorigenesis/metastasis assays, MDA-231-PG cells showed substantially lower and MDA-231-NPM-KD cells substantially higher invasiveness relative to the MDA-231 parental cells, and the co-expression of PG and NPM shRNA led to even further reduction of the invasiveness of MDA-231-PG cells. Furthermore, examination of the levels and localization of PG and NPM in primary biopsies of metastatic infiltrating ductal carcinomas revealed coordinated expression of PG and NPM. Together, the data suggest that PG may regulate NPM subcellular distribution, which may potentially change the function of the NPM protein from oncogenic to tumor suppression.
authors.affiliation: Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: L
authors.initials: L
authors.lastname: Lam
authors.forename: Z
authors.initials: Z
authors.lastname: Aktary
authors.forename: M
authors.initials: M
authors.lastname: Bishay
authors.forename: C
authors.initials: C
authors.lastname: Werkman
authors.forename: C-Y
authors.initials: CY
authors.lastname: Kuo
authors.forename: M
authors.initials: M
authors.lastname: Heacock
authors.forename: N
authors.initials: N
authors.lastname: Srivastava
authors.forename: J R
authors.initials: JR
authors.lastname: Mackey
authors.forename: M
authors.initials: M
authors.lastname: Pasdar
references.citation: J Biol Chem. 1988 Aug 5;263(22):10608-12
references.pmid: 3392030
references.citation: Am J Clin Pathol. 2010 Jan;133(1):34-40
references.pmid: 20023256
references.citation: Cold Spring Harb Perspect Biol. 2009 Aug;1(2):a002543
references.pmid: 20066089
references.citation: Int J Med Sci. 2011 Apr 20;8(4):287-94
references.pmid: 21537492
references.citation: J Pathol. 1996 Jan;178(1):48-52
references.pmid: 8778315
references.citation: J Cell Biol. 2002 Aug 19;158(4):695-708
references.pmid: 12186853
references.citation: PLoS One. 2010 Mar 24;5(3):e9849
references.pmid: 20352051
references.citation: Mol Cell Biol. 2000 Jun;20(12):4238-52
references.pmid: 10825188
references.citation: Mol Cell Biol. 2004 May;24(9):3703-11
references.pmid: 15082766
references.citation: Mol Cell Biol. 2004 Feb;24(3):985-96
references.pmid: 14729947
references.citation: Mol Cell Biol. 2004 Nov;24(21):9327-38
references.pmid: 15485902
references.citation: Int J Cell Biol. 2012;2012:189521
references.pmid: 22481945
references.citation: Biochemistry. 1989 Feb 7;28(3):1033-9
references.pmid: 2713355
references.citation: Mol Cell. 2003 Nov;12(5):1151-64
references.pmid: 14636574
references.citation: Nat Rev Cancer. 2006 Jul;6(7):493-505
references.pmid: 16794633
references.citation: Cancer Cell. 2004 May;5(5):465-75
references.pmid: 15144954
references.citation: Endocr Pathol. 2011 Mar;22(1):18-23
references.pmid: 21258971
references.citation: Br J Cancer. 2007 Feb 12;96(3):477-84
references.pmid: 17245342
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5420-5
references.pmid: 15805189
references.citation: J Biol Chem. 2000 Apr 14;275(15):10905-11
references.pmid: 10753888
references.citation: Leukemia. 2010 Oct;24(10):1813-6
references.pmid: 20724983
references.citation: J Biol Chem. 2009 Jun 12;284(24):16409-16418
references.pmid: 19366707
references.citation: Curr Opin Oncol. 2009 Nov;21(6):573-81
references.pmid: 19770764
references.citation: Oncogene. 2010 Apr 8;29(14):2118-29
references.pmid: 20101217
references.citation: Cell Motil Cytoskeleton. 1998;40(1):87-100
references.pmid: 9605974
references.citation: Mol Cell Biol. 2009 Sep;29(18):5115-27
references.pmid: 19581289
references.citation: Mol Carcinog. 2007 Oct;46(10):824-38
references.pmid: 17415780
references.citation: Chang Gung Med J. 2007 Jul-Aug;30(4):285-93
references.pmid: 17939258
references.citation: FEBS J. 2010 Aug;277(16):3321-42
references.pmid: 20618440
references.citation: Breast Cancer Res Treat. 2009 Dec;118(3):605-21
references.pmid: 19002577
references.citation: Cancer Res. 1992 Jun 15;52(12):3372-7
references.pmid: 1596895
references.citation: Prostate. 1999 Jun 1;39(4):298-304
references.pmid: 10344220
references.citation: EMBO J. 2004 May 19;23(10):2116-25
references.pmid: 15103331
references.citation: Leukemia. 2009 Oct;23(10):1731-43
references.pmid: 19516275
references.citation: Oncogene. 2008 Apr 17;27(18):2602-12
references.pmid: 17998942
references.citation: Cold Spring Harb Perspect Biol. 2009 Aug;1(2):a002881
references.pmid: 20066091
references.citation: Genes Dev. 2004 Aug 1;18(15):1862-74
references.pmid: 15289458
references.citation: Oncogene. 2006 Jul 20;25(31):4376-80
references.pmid: 16501600
references.citation: APMIS. 2007 Apr;115(4):341-6
references.pmid: 17504301
references.citation: Clin Cancer Res. 2009 Apr 15;15(8):2885-94
references.pmid: 19351769
references.citation: Exp Cell Res. 2011 Apr 15;317(7):966-75
references.pmid: 21182834
references.citation: Exp Mol Pathol. 2011 Feb;90(1):38-44
references.pmid: 21122805
references.citation: Am J Pathol. 2011 Aug;179(2):1004-14
references.pmid: 21689627
references.citation: Hum Pathol. 2010 Aug;41(8):1079-86
references.pmid: 20338617
references.citation: Mol Cell Biol. 2005 Oct;25(20):8874-86
references.pmid: 16199867
references.citation: J Steroid Biochem Mol Biol. 1998 Dec;67(5-6):391-402
references.pmid: 10030688
references.citation: Carcinogenesis. 2006 Sep;27(9):1758-67
references.pmid: 16537559
references.citation: Curr Opin Pharmacol. 2010 Dec;10(6):643-9
references.pmid: 20810315
references.citation: Nat Cell Biol. 2002 Jul;4(7):529-33
references.pmid: 12080348
references.citation: Br J Cancer. 2005 Jun 20;92(12):2153-9
references.pmid: 15942628
references.citation: Br J Cancer. 2007 Jun 18;96(12):1783-7
references.pmid: 17519903
references.citation: Cancer Res. 2007 Jul 1;67(13):6230-7
references.pmid: 17616680
references.citation: Cancer Res. 2010 Feb 15;70(4):1656-67
references.pmid: 20145123
references.citation: J Cell Biol. 2008 Jul 14;182(1):19-26
references.pmid: 18625840
references.citation: J Cell Biol. 2008 Jul 14;182(1):7-9
references.pmid: 18625839
references.citation: J Mol Histol. 2006 Sep;37(5-7):239-51
references.pmid: 16855788
references.citation: J Cell Sci. 2010 Oct 15;123(Pt 20):3576-86
references.pmid: 20876660
references.citation: Cell Cycle. 2009 Sep 1;8(17):2703-7
references.pmid: 19652540
references.citation: Oncogene. 2009 Sep 10;28(36):3209-20
references.pmid: 19561638
references.citation: Cancer Detect Prev. 2006;30(6):481-90
references.pmid: 17113241
references.citation: Blood. 2008 Apr 1;111(7):3859-62
references.pmid: 18212245
references.citation: J Cell Biol. 1996 Apr;133(1):199-209
references.pmid: 8601608
references.citation: Cancer Res. 2007 Oct 15;67(20):9781-90
references.pmid: 17942908
references.citation: J Proteome Res. 2005 Jul-Aug;4(4):1419-26
references.pmid: 16083295
references.citation: J Cell Sci. 1998 Apr;111 ( Pt 7):1005-19
references.pmid: 9490644
references.citation: J Cell Biol. 1988 Mar;106(3):687-95
references.pmid: 3279050
references.citation: Blood Rev. 2011 Nov;25(6):247-54
references.pmid: 21724308
references.citation: Acta Pharmacol Sin. 2008 Mar;29(3):364-70
references.pmid: 18298902
references.citation: Breast Cancer Res Treat. 2010 Jun;121(2):527-38
references.pmid: 19787450
references.citation: Oncogene. 2007 Apr 19;26(18):2554-62
references.pmid: 17072349